Goldman Sachs
BVS icon

Goldman Sachs’s Bioventus BVS Stock Holding History

Goldman Sachs’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.16M Buy
652,367
+178,983
+38% +$1.71M ﹤0.01% 3697
2026
Q1 		$4.32M Buy
473,384
+103,566
+28% +$869K ﹤0.01% 3849
2025
Q4 		$2.75M Sell
369,818
-22,582
-6% -$162K ﹤0.01% 4296
2025
Q3 		$2.63M Buy
392,400
+255,769
+187% +$1.77M ﹤0.01% 4242
2025
Q2 		$904K Sell
136,631
-25,781
-16% -$183K ﹤0.01% 4776
2025
Q1 		$1.49M Buy
162,412
+26,103
+19% +$261K ﹤0.01% 4388
2024
Q4 		$1.43M Sell
136,309
-25,964
-16% -$307K ﹤0.01% 4567
2024
Q3 		$1.94M Buy
162,273
+46,068
+40% +$398K ﹤0.01% 4180
2024
Q2 		$668K Sell
116,205
-98,124
-46% -$538K ﹤0.01% 4667
2024
Q1 		$1.11M Buy
214,329
+179,943
+523% +$879K ﹤0.01% 4275
2023
Q4 		$181K Buy
+34,386
New +$136K ﹤0.01% 5181
2023
Q3 		– Sell
-14,008
Closed -$40.5K – 5564
2023
Q2 		$40.5K Buy
14,008
+3,861
+38% +$7.41K ﹤0.01% 5483
2023
Q1 		$10.9K Sell
10,147
-29,090
-74% -$55.6K ﹤0.01% 5734
2022
Q4 		$102K Sell
39,237
-125,556
-76% -$548K ﹤0.01% 5475
2022
Q3 		$1.15M Buy
164,793
+108,130
+191% +$847K ﹤0.01% 4406
2022
Q2 		$386K Buy
56,663
+10,090
+22% +$103K ﹤0.01% 5264
2022
Q1 		$657K Buy
46,573
+5,538
+13% +$74.1K ﹤0.01% 5147
2021
Q4 		$594K Buy
+41,035
New +$583K ﹤0.01% 5255

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs's BVS Position: Q2 2026 in Review

Goldman Sachs increased its Bioventus (BVS) stake by 38% in Q2 2026, buying an estimated $1.71M and bringing the position to 652,367 shares worth $6.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3697.

Goldman Sachs first reported a position in BVS in Q4 2021 and has held it in 18 quarters since. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Goldman Sachs held 652,367 shares of Bioventus worth $6.16M as of Q2 2026.
  • Goldman Sachs bought 178,983 Bioventus shares in Q2 2026, an estimated $1.71M.
  • Bioventus made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3697 holding.
  • Goldman Sachs first reported a position in Bioventus in Q4 2021 and has held it in 18 quarters since.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.